Africure Pharmaceuticals Ltd (AFRP.mu) Q12022 Interim Report
Africure Pharmaceuticals Ltd (AFRP.mu) listed on the Stock Exchange of Mauritius under the Pharmaceuticals sector has released it’s 2022 interim results for the first quarter.
For more information about Africure Pharmaceuticals Ltd (AFRP.mu) reports, abridged reports, interim earnings results and earnings presentations visit the Africure Pharmaceuticals Ltd (AFRP.mu) company page on AfricanFinancials.
Africure Pharmaceuticals Ltd 2022 interim results for the first quarter
Company Profile
Africure Pharmaceuticals Ltd is a manufacturer and distributor of high quality essential medication in Africa. It was incorporated on 17 March 2017 and holds a Global Business Licence issued by the Financial Services Commission. The principal activity of the Company is investment holding, trading & procurement of pharmaceutical products. Africure Pharmaceuticals Ltd is listed on the Stock Exchange of Mauritius
Recent Documents & News
-
Articles
Africure Pharmaceuticals Ltd Achieves 70% of Budgeted Revenue in Q1 2024 with Revenues at USD 6.57 Mn – September 6, 2023 -
Interim Reports
Africure Pharmaceuticals Ltd (AFRP.mu) Q12024 Interim Report – September 5, 2023 -
Articles
Africure Pharmaceuticals Ltd achieved 90% of its budgeted revenue & profitability estimates – July 17, 2023 -
Abridged Reports
Africure Pharmaceuticals Ltd (AFRP.mu) 2023 Abridged Report – July 3, 2023 -
Annual Reports
Africure Pharmaceuticals Ltd (AFRP.mu) 2022 Annual Report – June 19, 2023
